STROKE PREVENTION: Antiplatelet and Antithrombolytic Therapy
- 1 May 2000
- journal article
- review article
- Published by Elsevier in Neurologic Clinics
- Vol. 18 (2) , 343-355
- https://doi.org/10.1016/s0733-8619(05)70196-1
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial originJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Thrombotic thrombocytopenic purpura after stenting and ticlopidineThe Lancet, 1998
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- High-dose acetylsalicylic acid after cerebral infarction. A Swedish Cooperative Study.Stroke, 1987
- Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group.Stroke, 1985
- "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.Stroke, 1983
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978